MedTrace Logo

Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients

NCT00576394 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2015-06-23

No results posted yet for this study

Summary

entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.

Conditions

  • Glycemic Control

Interventions

DRUG

IV Insulin drip

IV insulin drip at 100units insulin in 100ml saline designed to keep blood glucose between 120-180mg/dl

DRUG

Insulin

IV insulin drip to keep serum glucose between 80-120mg/dl.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00576394 on ClinicalTrials.gov